Compare Novavax Inc (NVAX) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Solaredge Technologies Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Solaredge Technologies Inc trades at $50.3 (market cap $2.96B). The key difference: Solaredge Technologies Inc is far larger — about 2.3× Novavax Inc's market cap, and Solaredge Technologies Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SEDG | |
|---|---|---|
Market Cap | $1.30B | $2.96B |
Sector | Health | Technology |
52-Week High | $11.19 | $78.51 |
52-Week Low | $6.22 | $24.42 |
Enterprise Value | $800.50M | $2.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
